Product Information
PRAZOSIN 2 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0850 per EA under NDC 00093406810. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Sep 12, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Prazosin Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093406810
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PRAZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA071745FDA Approved
9/12/1988
TE Code
AB
On Market Since
2/22/2007
Pharmacological Classes
Price Statistics
The NADAC for PRAZOSIN 2 MG CAPSULE has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 66.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.6915 (Jun 15, 2016) |
| All-time low | $0.0823 (Jun 17, 2026) |
| 52-week high | $0.0940 |
| 52-week low | $0.0823 |
| Median price | $0.3817 |
| Average price | $0.3666 |
| Largest weekly change | -31.4% (Apr 17, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PRAZOSIN 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRAZOSIN 2 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $0.0850 per EA (NDC 00093406810), effective Aug 19, 2026.
How has the price of PRAZOSIN 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRAZOSIN 2 MG CAPSULE has declined 66.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PRAZOSIN 2 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PRAZOSIN 2 MG CAPSULE has ranged from a low of $0.0823 (Jun 17, 2026) to a high of $0.6915 (Jun 15, 2016), with a median of $0.3817 per EA.
Are there cheaper alternatives to PRAZOSIN 2 MG CAPSULE?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAZOSIN 2 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAZOSIN 2 MG CAPSULE?
PRAZOSIN 2 MG CAPSULE (NDC 00093406810) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.